News | August 04, 2008

New GE CT Scanner Technology Captures Rodent Heart Beat at 600 Beats-Per-Minute

August 5, 2008 - GE Healthcare today released a new pre-clinical computed tomography scanner specifically designed to accelerate research in the areas of cardiac disease and drug development.

The GE eXplore CT 120 scanner is an all-new design based on years of research CT scanner experience, GE officials said. Using X-ray source technology derived from clinical systems, the eXplore CT 120 features 100 times the output of previous GE laboratory research imaging systems. This power enables X-ray exposures fast enough and detailed enough to capture the motion of a beating mouse heart, and brings the power of cardiac CT imaging to a popular mammal used in disease research and drug development.

The power of the new X-ray source also allows for more effective filtering of the X-ray beam, reducing the X-ray dose to the research subject compared to previous scanners, while greatly reducing the scan time.

“Morphological imaging is the key to understanding cardiac kinetics,” said Professor André Constantinesco of Hôpitaux Universitaires de Strasbourg. “This scanner provides us the ability to acquire 4D, high-resolution datasets in living mice, improving our ability to quantify rodent models of cardiac diseases.”

The scanner’s user software is designed for throughput and, with its powerful computing hardware, makes the scanner four times faster than previous designs. Industry-standard DICOM compatibility and an optional analysis workstation assist in timely image analysis and production of research data.

For more information: www.gehealthcare.com


Related Content

News | Cardiovascular Clinical Studies

May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular ...

Home May 02, 2024
Home
News | Cardiovascular Clinical Studies

May 1, 2024 — A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is ...

Home May 01, 2024
Home
News | Cardiovascular Clinical Studies

April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart ...

Home April 30, 2024
Home
News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
Subscribe Now